for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Gsk Announces FDA Approval For Nucala For Use In Adults With Chronic Rhinosinusitis With Nasal Polyps

July 29 (Reuters) - GlaxoSmithKline PLC:

* GSK ANNOUNCES FDA APPROVAL FOR NUCALA (MEPOLIZUMAB) FOR USE IN ADULTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up